Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Fat3 ELISA Kit (AC3664)
Cat.#: ASET-2253
Specifications
Description Mouse Fat3 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Fat3 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.023 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1756 Rat HEXA ELISA Kit (AC3167) Quantitative inquiry ASET-1327 Human Rabphilin 3A ELISA Kit (AC2738) Quantitative inquiry ASET-2176 Human Bim ELISA Kit (AC3587) Quantitative inquiry ASET-1418 Mouse Aromatase ELISA Kit (AC2829) Quantitative inquiry ASET-2373 Mouse Nurr1 ELISA Kit (AC3784) Quantitative inquiry ASET-1903 Human DUOX1 ELISA Kit (AC3314) Quantitative inquiry ASET-1003 Porcine GLP1 ELISA Kit (AC2414) Quantitative inquiry ASET-2447 Human Neuropilin 1 ELISA Kit (AC3858) Quantitative inquiry ASET-1597 Human Laminin ELISA Kit (AC3008) Quantitative inquiry ASET-1223 Mouse Gprin1 ELISA Kit (AC2634) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket